ÂÜÀòÂÒÂ×

Janet Lee has extensive experience in the biopharmaceutical industry, particularly in process development for allogeneic CAR T therapies. Currently serving as Associate Director and Principal Scientist at Allogene Therapeutics since 2018, Janet has a strong background in designing and executing experiments using Design of Experiments (DOE) methodologies. Previous roles include positions at Pfizer and Cedars-Sinai, where efforts focused on optimizing large-scale production of allogeneic CAR T cells and investigating genetic susceptibility to ovarian cancer. Educational qualifications include a Master of Science in Biochemistry and Molecular Biology from the Keck School of Medicine of the University of Southern California and a Bachelor of Science in Chemistry from the University of California, Berkeley.